Interstitial lung disease induced by Toripalimab combined with disitamab Vedotin in upper tract urothelial carcinoma: a case report and literature review

Abstract Background Upper tract urothelial carcinoma (UTUC) is a rare subtype of urothelial cancer, accounting for only 5–10% of cases, and is characterized by aggressive biological behavior. Recent advances in immune checkpoint inhibitors (ICIs) and antibody-drug conjugates (ADCs) have expanded the...

Cijeli opis

Bibliografski detalji

Glavni autori:	Peng Ding, Huanhuan Lin, Kaichen Zhang, Qian Yang, Peiyang Gao
Format:	Artigo
Jezik:	Inglês
Izdano:	BMC 2025-07-01
Serija:	BMC Pulmonary Medicine
Teme:	Toripalimab Disitamab Vedotin Interstitial lung disease Upper tract urothelial carcinoma Glucocorticoid Case report
Online pristup:	https://doi.org/10.1186/s12890-025-03838-z
Oznake:	Dodaj oznaku Bez oznaka, Budi prvi tko označuje ovaj zapis!